Penumbra has secured U.S. FDA clearance for THUNDERBOLT, the first computer-assisted vacuum thrombectomy (CAVT) device cleared in the United States for acute ischemic stroke. The Alameda-based company says THUNDERBOLT extends its CAVT platform from the body's vasculature into the brain, marking what it calls the start of a new era in stroke care.
Modulated aspiration powered by the Penumbra ENGINE
THUNDERBOLT is powered by the Penumbra ENGINE and introduces modulated aspiration to the company's neuro thrombectomy portfolio. The system is designed to detect, fatigue, and ingest a blood clot at the site of an occlusion, and ships pre-packaged with one of Penumbra's RED catheters — RED 62, RED 68, RED 72 SILVER LABEL or RED 72 SILVER LABEL with SENDit technology.
"Stroke is the second leading cause of death worldwide and with stroke, timing is critical," said Dr. Donald Frei, neurointerventional radiologist at Swedish Medical Center in Denver, in Penumbra's release. "What sets THUNDERBOLT apart is the innovative design which minimizes catheter manipulation and promotes safe, complete clot capture, quickly restoring blood flow to the brain."
A widening clot-care platform
Stroke mortality is projected to rise 50% between 2020 and 2050 globally, and in the U.S. someone has a stroke every 40 seconds. THUNDERBOLT is now the only CAVT device available for stroke treatment in the country, a position Penumbra president Shruthi Narayan framed as redefining "blood clot care from head-to-toe."
A more crowded U.S. surgical-robotics field
The clearance lands as the U.S. surgical-robotics market keeps absorbing new platforms. CMR Surgical has begun its U.S. launch of Versius Plus, Stereotaxis is rolling out GenesisX in a limited launch, and Medtronic recently filed Hugo 510(k)s for U.S. general and gynecologic surgery. THUNDERBOLT's unique angle is neurovascular: not a multi-arm console, but a procedural device that pulls AI-modulated aspiration into the highest-time-pressure setting in interventional medicine.
Reporting based on coverage from Surgical Robotics Technology and Penumbra, Inc.